Female-and male-specific risk factors for stroke a systematic review and meta-analysis

JAMA Neurology

Volumn 74, Issue 1, 2017, Pages 75-81

  Poorthuis, Michiel H F ^a   Algra, Annemijn M ^a   Algra, Ale ^a   Kappelle, L Jaap ^a   Klijn, Catharina J M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ECLAMPSIA; ERECTILE DYSFUNCTION; FEMALE; HUMAN; HYSTERECTOMY; INCIDENCE; MALE; MATERNAL HYPERTENSION; MENOPAUSE; MORTALITY; ORCHIECTOMY; OVARIECTOMY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; STILLBIRTH; SYSTEMATIC REVIEW; BIBLIOGRAPHIC DATABASE; META ANALYSIS; RISK FACTOR; SEXUAL DEVELOPMENT; STATISTICS AND NUMERICAL DATA; STROKE;

DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; MALE; RISK FACTORS; SEX CHARACTERISTICS; STROKE;

EID: 85011409159     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.3482     Document Type: Article

References (39)

1. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009;40(4):1082-1090.
2. Löfmark U, Hammarström A. Evidence for age-dependent education-related differences in men and women with first-ever stroke: results from a community-based incidence study in northern Sweden. Neuroepidemiology. 2007;28(3):135-141.
3. Rothwell PM, Coull AJ, Silver LE, et al; Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366(9499): 1773-1783.
4. Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M. Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27(1):35-45.
5. Algra AM, Klijn CJ, Helmerhorst FM, Algra A, Rinkel GJ. Female risk factors for subarachnoid hemorrhage: a systematic review. Neurology. 2012; 79(12):1230-1236.
6. Main C, Knight B, Moxham T, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2013;4(4):CD002229.
7. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
8. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of Observational Studies in Epidemiology: a proposal for reporting: Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283 (15):2008-2012.
9. Alonso de Leciñana M, Egido JA, Fernández C, et al; PIVE Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group. Risk of ischemic stroke and lifetime estrogen exposure. Neurology. 2007;68(1):33-38.
10. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159(2):215-221.e6. doi:10 .1016/j.ahj.2009.11.017
11. Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. JWomens Health (Larchmt). 2004;13(4):381-389.
12. Park JK, Kim HJ, Chang SJ, Koh SB, Koh SY. Risk factors for hemorrhagic stroke inWonju, Korea. Yonsei Med J. 1998;39(3):229-235.
13. Zhang X, Shu XO, Gao YT, Yang G, Li H, Zheng W. Pregnancy, childrearing, and risk of stroke in Chinese women. Stroke. 2009;40(8):2680-2684.
14. Vigen R, O'Donnell CI, Barón AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836.
15. Yeap BB, Hyde Z, Almeida OP, et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab. 2009;94(7):2353-2359.
16. Schooling CM. Androgen activity, ischaemic heart disease and risk factors among men in NHANES III. Eur J Clin Invest. 2013;43(12):1273-1281.
17. Brown MC, Best KE, Pearce MS,Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1-19.
18. Romundstad PR,Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122(6):579-584.
19. Report of the National High Blood Pressure Education ProgramWorking Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(1):S1-S22.
20. Heida KY, Velthuis BK, Oudijk MA, et al; Dutch Guideline Development Group on Cardiovascular Risk Management After Reproductive Disorders. Cardiovascular disease risk in women with a history of spontaneous preterm delivery: a systematic review and meta-analysis. Eur J Prev Cardiol. 2015; 23(3):253-263.
21. Oliver-Williams CT, Heydon EE, Smith GC,Wood AM. Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis. Heart. 2013;99(22):1636-1644.
22. Charalampopoulos D, McLoughlin A, Elks CE, Ong KK. Age at menarche and risks of all-cause and cardiovascular death: a systematic review and meta-analysis. Am J Epidemiol. 2014;180(1):29-40.
23. Prentice P, Viner RM. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes (Lond). 2013;37(8):1036-1043.
24. Roeters van Lennep JE, Heida KY, Bots ML, Hoek A; Collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management After Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(2):178-186.
25. Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J. 2011;32(6):745-750.
26. Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatalmyocardial infarction following testosterone therapy prescription in men. PLoS One. 2014;9(1):e85805. doi:10.1371/journal .pone.0085805
27. Morgentaler A, Miner MM, Caliber M, Guay AT, KheraM, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224-251.
28. Azoulay L, Yin H, Benayoun S, Renoux C, Boivin JF, Suissa S. Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer. Eur Urol. 2011;60(6):1244-1250.
29. Wu FC, Tajar A, Pye SR, et al; European Male Aging Study Group. Hypothalamic-pituitarytesticular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737-2745.
30. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-731.
31. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007;92(2):549-555.
32. Morley JE, Kaiser FE, Perry HMIII, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46(4):410-413.
33. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589-598.
34. Soisson V, Brailly-Tabard S, Helmer C, et al. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas. 2013;75(3):282-288.
35. Shores MM, Arnold AM, Biggs ML, et al. Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study. Clin Endocrinol (Oxf). 2014;81(5):746-753.
36. Yeap BB, Alfonso H, Chubb SA, et al. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but notmyocardial infarction. J Clin Endocrinol Metab. 2014;99(12): 4565-4573.
37. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47(1):80-85.
38. de Groot PC, Dekkers OM, Romijn JA, Dieben SW, Helmerhorst FM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495-500.
39. Bushnell C, McCullough LD, Awad IA, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association [published corrections appear in Stroke. 2014;45(5):e95 and 2014;45(10):e214]. Stroke. 2014;45(5):1545-1588.